AstraZeneca: Investor AB stake falls under 4%
(CercleFinance.com) - Swedish investment firm Investor AB's stake in AstraZeneca has been reduced from 4.
02% to 3.93%, according to a regulatory filing late on Thursday.
This move is due to a change in the total voting rights notified by AstraZeneca on 2 April, the filing shows.
Copyright (c) 2019 CercleFinance.com. All rights reserved.
02% to 3.93%, according to a regulatory filing late on Thursday.
This move is due to a change in the total voting rights notified by AstraZeneca on 2 April, the filing shows.
Copyright (c) 2019 CercleFinance.com. All rights reserved.